DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20205207

Corona virus epidemiology: a review article

Kamlesh Sharma, Ram Lal Sharma, Vanita Sharma

Abstract


Corona virus disease-2019 is an infectious disease caused by SARS-Co-2. The disease started in December 2019 in Wuhan, China resulting in pandemic. Common symptoms are fever, cough and shortness of breath. Loss of apetite, anosmia, conjunctivitis and diarrhoea are fewer common symptoms. The disease is mild in most people but may progress to pneumonia, acute respiratory distress syndrome in elderly patients and those with co-morbidities. The infection is spread from one person to another via respiratory droplets or contact with infected droplets. Preventive measures include frequent and thorough hand washing, maintaining distance from potential transmitter and not touching one’s face. Mask is recommended to suspects and to their caregivers. Presently there is no vaccine or specific treatment for COVID-19. Management involves treatment of symptoms, supportive care. World health organisation declared the 2019-2020 CoV outbreak a pandemic and a Public Health Emergency of International concern with death rate of 3.4%.


Keywords


Coronavirus disease-19, SARS-CoV-2, Pandemic, Pneumonia, World health organization

Full Text:

PDF

References


World Health Organisation. what you need to know 2020. Available at: http://www. afro.who.int>news>coronavirus-disease-what-you-need-know/WHO. Accessed on 08 April 2020

Estola T. Coronaviruses, a New Group of Animal RNA Viruses. Avi Dise. 1970;14:330-6

Fabricant J. The Early History of Infectious Bronchitis. Avi Disea. 1998;42:648-50.

Decaro N. Gammacoronavirus. In: Tidona C, Darai G,eds. Gammacoronavirus‡: Coronaviridae. The Springer Index of Viruses. 1st ed. Springer. 2011: 403-13.

McIntosh K. Coronaviruses: a comparative review. InCurrent Topics in Microbiology and Immunology/Ergebnisse der Mikrobiologie und Immunitätsforschung. Sprin. 1974:85-129.

II était une fois less coronavirus. Réalités Biomédicales (in French). 2020-03-27. Available at: https://en.wikipedia.org/wiki/Coronavirus. Accessed on 03 November 2020

Ramesha T. Effect of COVID-19 and Historical Background – An Overview. J Emerg Technol Innovat Res. 2020;7:4.

Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. Epidemiology,Genetic Recombination and Pathogenesis of Coronaviruses. Tre Microbiol. 2016;24:490-502.

Bonilla PJ, Gorbalenya AE, Weiss SR. Mouse hepatitis virus strain A59 RNA polymerase gene ORF 1a: heterogeneity among MHV strains. Virology. 1994;198:736-40.

Navas S, Weiss SR. Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism. J Virol. 2003; 77:4972-8.

Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang GS, Holmes KV et al. Cloning of the mouse hepatitis virus (MHV) receptor expression in human and hamster cell lines confers susceptibility to MHV. J Virol. 1991;65:6881-91

Yeager CL, Ashen RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 1992;357:420-2.

Gallagher TM, Escarmis C, Buchmeier MJ. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J Virol. 1991;65:1916-28.

Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450-4.

Denison MR, Spaan WJ, van der Meer Y, Gibson CA, Sims AC, Prentice E et al. The putative helicase of the coronavirus mouse hepatitis virus is processed from the replicase gene polyprotein and localizes in complexes that are active in viral RNA synthesis. J Virol. 1999;73:6862-71.

de Vries AAF, Horzinek MC, Rottier PJM, de Groot RJ. The genome organization of the nidovirales: similarities and differences between arteri-, toro-, and coronaviruses. Sem Virol. 1997;8:33-47.

Bost AG, Carnahan RH, Lu XT, Denison MR. Four proteins processed from the replicase gene polyprotein of mouse hepatitis virus colocalize in the cell periphery and adjacent to sites of virion assembly. J Virol. 2000;74:3379-87.

Opstelten DJ, Raamsman MJ, Wolfs K, Horzinek MC, Rottier PJ. Envelope glycoprotein interactions in coronavirus assembly. J Cell Biol. 1995;131:339-49.

Salanueva IJ, Carrascosa JL, Risco C. Structural maturation of the transmissible gastroenteritis coronavirus. J Virol. 1999;73:7952-64.

McIntosh K, Kapikian AZ, Turner AZ, Hartley JW, Parrot RH, Chanock RM. Seroepidemiological studies of coronavirus infection in adults and children. Am J Epidemiol. 1970;91:585-92.

Zeng ZQ, Chen DH, Tan WP, Qiu SY, Xu D, Liang HX et al. Epidemiology and clinical characteristics of human coronaviruses OC43,229E,NL63 and HKU1: a study of hospitalized children with acute respiratory infections in Guangzhou, China. Eur J Clin Microbial Infect Dis. 2018;37:363-9.

Monto AS. Medical reviews. Coronaviruses. Yale J Biol Med. 1974;47:234.

Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, NL63 and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbial. 2010;48:2940-7.

Heimdal I, Moe n, Krokstad S, Christensen A, Skanke LH, Nordbo SA et al. Human coronavirus in Hospitalized Children With Respiratory Tract Infections: A 9-year Population Based Study From Norway. J Infect Dis. 2019;219:1198-206.

World health organization. Pneumonia of unknown cause-China Emergencies preparedness, response, disease outbreak news 2020. Available at: http://www.who.int>csr>don. Accessed on 01 November 2020.

Who Director General remarks at the media briefing on 2019-nCov on 11th february2020 Available at https/www/.who.int/dg/speeches/detail/who-director-general- remarks at the media briefing on 2019 nCov on 11 february 2020. Accessed on 05 July 2020.

Coronavirus Study Group of the International Concern on Taxonomy of Viruses.The species severe acute respiratory syndrome-related coronavirus classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020

28. WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020. Available at https://www.who.int/dg/speeches/ detail/who-director-general-s-opening -remarks-at-the-media-briefing-on-covid-19-11 march-2020. Accssed on 07 July 2020.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ , He JX et al. Clinical characteristics of coronavirus disease 2019 in China. N EnJMedic. 2020;382

Worldometer 2020. Available at www. wordlometer.info> coronavirus>country>India. Accessed on 3 november 2020.

COVID 19 Disease Response/Situation Report, 2020. Available at http://www.who.in>corona virus disease. Accessed on 03 November 2020.

COVID-19 India situation update report, 2020. Available at https://www.who. int/india/emergencies/India-situation-report. Accessed on 18August 2020.

Coronavirus LIVE 2020. Available at http://www. >coronavirus>News. Accessed on 03 November 2020.

Coronavirus Cases in India: Covid -19 Pandemic Outbreak,2020. Available at http://www. times of india.indiatimes.com. Accessed on 03 november 2020.

Reed SE. The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains. J Med Virol. 1984;13:179.

Gagneur A, Vallet S, Taibot PJ, Legrand-Quillien MC, Picard B, Payan C et al. Outbreak of human coronavirus in a pediatric and neonatal intensive care unit. Eur J Pediatr. 2008;167:1427-34.

Falsey AR, Dallal GE, Formica MA, Andolina GG, Hamer DH, Leka LL et al. Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc. 2008;56:1281-5

Ye ZW, Yuan S, Yuan KS, Fung SN, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sc. 2020;16:1686-97.

World Health Organization. Available at: http://www.afro.who.int.>publications>coronavirus. Accessed on 08 April 2020.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C et al. Pathological findings of COVID‐19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420‐2.

Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S et al. Acute disseminated encephalomyelitis. Neurology. 2016; 87:S38–45.

Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74:8913.

Ester F, Shapiro ED, Webel C, Ferguson D, Landry ML, KahnSJ et al. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis. 2005;191:499-502.

Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IFN, Poon LL M et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-72.

Gao QY, Chen YX, Fang JY. 2019 Novel coronavirus infection and gastrointestinal tract. J Dig Dis. 2020;21:125‐6.

Song Y, Liu P, Shi XL, Chu YL, Zhang J, Xia J et al. SARS‐CoV‐2 induced diarrhoea as onset symptom in patient with COVID‐19. Gut. 2020;69: 1143‐4.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:507‐13.

48. Jin XH, Zheng KI, Pan KH, Xie YP, Zheng MH. COVID‐19 in a patient with chronic lymphocytic leukaemia. Lancet Haematol. 2020;7:e351‐2.

Brooks SK, Webster RK, Smith LE, Woodland Lisa, Wessely S, Greenberg N et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912‐20.

Marjanovic Z, Greenglass ER, Coffey S. The relevance of psychosocial variables and working conditions in predicting nurses coping strategies during the SARS crisis: an online questionnaire survey. Int J Nurs Stud. 2007;44:991‐8.

Zheng IK, Feng G, LiuWY, Targher G, Byrne DC, Zheng MH. Extra pulmonary complications of COVID-19: A multi system disease. J of Medic Virol. 2020.

Adeel AA. Perspectives on Repositioning Chloroquine and Hydroxychloroquine for the Treatment of Covid-19. Sudanese J Pediatric. 2020;20:4-9.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019- nCoV) in vitro. Cell Res. 2020;30:269-71.

Vora A, Arora VK, Behera D. White paper on Ivermectin as a potential therapy for COVID-19. Ind J Tuberc. 2020;67:448–51.